<DOC>
	<DOCNO>NCT02391844</DOCNO>
	<brief_summary>This pilot trial use product patient management pain outpatient arthroscopic knee surgery . This open-label study two active ingredient well know pharmacologic entity .</brief_summary>
	<brief_title>Open-Label Study Oxycodone/APAP Treat Post-Operative Pain Following Arthroscopic Knee Surgery</brief_title>
	<detailed_description>The objective single center evaluate safety efficacy Oxycodone Extended Release ( MNK-795 ) postoperative pain follow common musculoskeletal surgical procedure . Knee surgery common surgery perform US , investigator choose model . The investigator also want look flexible-dosing titration common way pain manage clinician . This open-label study MNK 795 describe procedure section . Primary endpoint : â€¢ Change pain baseline ( take first dose study medication ) measure NRS Secondary endpoint : - Patient/Investigator Global assessment treatment satisfaction - Safety evaluation adverse event monitoring</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>1 . Individuals age 1875 underwent orthopedic outpatient surgical procedure knee 2 . Read understand English comprehend procedure associate participate clinical trial . 3 . Signed IRB approve consent form HIPAA authorization 4 . Patients pain intensity score 4 010 numerical rating scale ( 0 pain , 10 bad pain imaginable ) 1 . Participants clinical trial last 30 day currently enrol clinical trial 2 . Allergy Oxycodone Acetaminophen . 3 . Uncontrolled pain pain condition may interfere evaluation 4 . Pregnant woman 5 . Women try become pregnant 6 . Women breastfeed 7 . Patient deem medically unstable principal investigator 8 . History Alcohol , opioid substance abuse last 2 yrs 9 . History sleep apnea require CPAP 10 . History serious respiratory illness 11 . History Gastric bypass 12 . Prior use opiates dose high 90mg Morphine equivalent dose 13 . Will limit study medication 4 tab dose total dose 8 tab 24 hr . Subjects need dos higher , base current opioid dose , enrol discontinue</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Knee</keyword>
	<keyword>Post-Operative Pain</keyword>
	<keyword>Xartemis</keyword>
</DOC>